<DOC>
	<DOCNO>NCT00391872</DOCNO>
	<brief_summary>Ticagrelor new , reversible binding , anti-platelet medication . Anti-platelet medication work prevent formation blood clot . Ticagrelor develop treatment patient acute coronary syndrome ( ACS ) . ACS term use describe heart attack progress imminent threat heart attack . ACS usually cause formation blood clot artery partially totally block blood supply portion heart muscle . Ticagrelor compare clopidogrel determine drug , either use conjunction aspirin , good reduce death vascular cause , future heart attack and/or stroke patient ACS .</brief_summary>
	<brief_title>A Comparison Ticagrelor ( AZD6140 ) Clopidogrel Patients With Acute Coronary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Male female 18 year old hospitalise chest pain potential ACS Females childbearing potential must negative pregnancy test enrollment willing use 2 method reliable contraception Persons moderate severe liver disease Persons already treat invasive ( angioplasty ) procedure current episode ACS Persons treat blood clot agent stop</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>ACS</keyword>
	<keyword>Acute coronary syndrome</keyword>
	<keyword>Heart attack</keyword>
	<keyword>Unstable angina</keyword>
	<keyword>Coronary artery disease</keyword>
</DOC>